Document is current
Any future updates will be listed below
-
Authors
Altay, Melek Firat
Liu, Alan King Lun
Holton, Janice L.
Parkkinen, Laura
Lashuel, Hilal A. https://orcid.org/0000-0001-7682-8320
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31ER30_186198)
Michael J. Fox Foundation for Parkinson's Research (MJFF-020698)
- License Information
-
More Information
Article History
Received: 1 July 2022
Accepted: 24 October 2022
First Online: 12 November 2022
Declarations
:
: Prof. Hilal A. Lashuel is the co-founder and chief scientific officer of ND BioSciences, Epalinges, Switzerland, a company that develops diagnostics and treatments for neurodegenerative diseases (NDs) based on platforms that reproduce the complexity and diversity of proteins implicated in NDs and their pathologies. H.L.A has received funding from industry to support research on neurodegenerative diseases, including Merck Serono, UCB, and Abbvie. These companies had no specific role in the conceptualization, preparation of and decision to publish this manuscript. All other authors have no conflict of interest.
